Skip to content

MINICARE

Active
Private limited companyfounded 2024active for 2 yearsAvenue des Merles 12, 1410 Waterloo, BelgiumKBO/BCE: BE 1010.914.501
Summary

MINICARE has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €93,934 and a net result of €115,934. The computed 12-month bankruptcy probability is 0.6% (low).

Overview

Overview

Official details

Source: KBO
Status
Active since 28-06-2024 Normal situation
Activity
“L'exercice, en son nom et pour son compte, de la médecine, plus particulièrement de…” (deed in French)From the articles, 19 activitiesNo NACE code in the KBO yet
Establishment unit
2.366.784.162 1410 Waterloo, since 01-08-2024
Financial year end
31 December
Peppol
Reachable since 01-07-2025

Board and ownership

Financial position

72 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
0.6%
Annual accounts 2025
Gross margin
€163,823
Turnover
≈ €410,000
estimated
Profit
€115,934
Equity
€93,934
Total assets
€172,896
  • 2025 accounts filed 25 days after the deadline
Score breakdownraises risk1 change of registered office in 24 monthsFounded in 2024lowers riskLiquidity: current ratio 2.19, cash €172,896Size: total assets €172,896Show the evidence

Checked score

Score 2025
72 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially stronger than 69% of micro companies without a NACE code
Financial strength
Strong
Solvency 79
equity 54.3% of total assets
Liquidity 78
short-term debt 45.7% · cash 100.0%
Profitability 100
return on assets 67.1%
Bankruptcy probability within 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%

About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 07-2025: 7.0% 08-2025: 7.0%● unchanged vs 07-2025 09-2025: 7.2%▲ +0.2 percentage points vs 08-2025 10-2025: 7.8%▲ +0.6 percentage points vs 09-2025 11-2025: 8.1%▲ +0.3 percentage points vs 10-2025 12-2025: 8.7%▲ +0.6 percentage points vs 11-2025 01-2026: 8.7%● unchanged vs 12-2025 02-2026: 8.8%▲ +0.1 percentage points vs 01-2026 03-2026: 8.8%● unchanged vs 02-2026 04-2026: 8.6%▼ -0.2 percentage points vs 03-2026 05-2026: 8.7%▲ +0.1 percentage points vs 04-2026 06-2026: 9.3%▲ +0.6 percentage points vs 05-2026 07-2026: 9.4%▲ +0.1 percentage points vs 06-2026highest value 08-2026: 9.4%● unchanged vs 07-2026highest value 09-2026: 0.6%▼ -8.8 percentage points vs 08-2026lowest value 10-2026: 0.6%● unchanged vs 09-2026lowest value 11-2026: 0.6%● unchanged vs 10-2026lowest value
Credit of up to €6,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 2.19, above the usual 1.5. Short-term debt is 45.7% and cash 100% of total assets. 45.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 47% of them on solvency, 71% on liquidity and 90% on profitability.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
lowers risk · Liquidity: current ratio 2.19, cash €172,896
NBB · annual accounts
lowers risk · Size: total assets €172,896
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
raises risk · Founded in 2024
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · 2025 accounts filed 25 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-08-2026, 25 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 1 filing
Deviation from the deadline
2025
25 days late
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Financials

Financials · financial year 2025, micro format

2025 annual accounts filed 25 days after the deadline Filed on 25 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00420470.

Annual accounts 2025 filed on 25-08-2026 at the NBB

Turnover
≈ €410,000
Estimated: probably between €270,000 and €630,000
Total assets
€172,896
Net result
€115,934
Working capital
€93,934

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Balance-sheet composition
Equity and liabilities €172,896
Equity €93,934
Debt €78,962
Debt's share of the balance-sheet total is 45.7%.
Key figures and ratios
2025 value
Current ratio
2.19
Debt to equity
0.84
ROE
123.4%
ROA
67.1%
Debt ≤ 1 year
€78,962
Income taxes
€47,679
Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 31 lines
Balance sheet Code2025
Assets
Total assets20/58€172,896
Current assets29/58€172,896
Cash at bank and in hand54/58€172,896
Equity and liabilities
Total equity and liabilities10/49€172,896
Equity10/15€93,934
Contributions10/11€2,000
Reserves13€90,000
Distributable reserves133€90,000
Profit (loss) carried forward14€1,934
Amounts payable17/49€78,962
Amounts payable within one year42/48€78,962
Trade debts44€7,146
Suppliers440/4€7,146
Taxes, remuneration and social security45€57,279
Taxes450/3€57,279
Other amounts payable47/48€14,537
Income statement Code2025
Gross operating margin9900€163,823
Operating profit (loss)9901€163,823
Financial income75/76B€24
Recurring financial income75€24
Financial charges65/66B€234
Recurring financial charges65€234
Profit (loss) for the period before taxes9903€163,613
Income taxes67/77€47,679
Profit (loss) for the period9904€115,934
Profit (loss) for the period to be appropriated9905€115,934
Appropriation of the result
Profit (loss) to be appropriated9906€115,934
Transfer to equity691/2€90,000
To other reserves6921€90,000
Profit to be distributed694/7€24,000
Return on contributions (dividend)694€24,000

The notes to these accounts have 1 item. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 25-08-2026.

Line2025
Gross operating margin9900€163,823
Operating profit (loss)9901€163,823
Financial income75/76B€24
Recurring financial income75€24
Financial charges65/66B€234
Recurring financial charges65€234
Profit (loss) for the period before taxes9903€163,613
Income taxes67/77€47,679
Profit (loss) for the period9904€115,934
Profit (loss) for the period to be appropriated9905€115,934
Line2025
Assets
Total assets20/58€172,896
Current assets29/58€172,896
Cash at bank and in hand54/58€172,896
Equity and liabilities
Total equity and liabilities10/49€172,896
Equity10/15€93,934
Contributions10/11€2,000
Reserves13€90,000
Distributable reserves133€90,000
Profit (loss) carried forward14€1,934
Amounts payable17/49€78,962
Amounts payable within one year42/48€78,962
Trade debts44€7,146
Suppliers440/4€7,146
Taxes, remuneration and social security45€57,279
Taxes450/3€57,279
Other amounts payable47/48€14,537
Line2025
Profit (loss) for the period9904€115,934
Operating cash flow (approximation)€115,934

A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.

Download as CSV

Historical observation

In July 2024, 39,278 companies had the same profile as MINICARE has now. Two years later, 95.8% were still going and 1.8% had gone bankrupt.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
95.8% was still going
2.3% stopped otherwise
1.8% went bankrupt

Another 0.1% stopped without a precise date, possibly only after those two years.

That fits the bankruptcy probability of MINICARE itself: 0.6% within 12 months.

Test of the method

The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,278 companies, not a prediction for MINICARE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Filings with the National Bank (1)
Financial year Type Filed Reference Document
31-12-2025 micro format 25-08-2026 2026-00420470 PDF

Board & ownership

Directors

Directors
1 director, no change since 2024
MAGERMAN Clémentine Jean-Louis Elisabeth Michèle Murielle
Director (not named in the articles) · since 28-06-2024 · term without a fixed end · listed in the 2025 annual accounts, filed on 25-08-2026
Current

Owners and capital

Shareholders

At incorporation act of 02-07-2024 ↗

Capital transactions

Capital over time
  1. 02-07-2024 Incorporation · €2,000 · 100 shares

Articles of association

Authorised capitalThe board may raise the capital up to this amount without a new shareholder decision.
“Émettre des actions nouvelles, des obligations convertibles ou des droits de souscription, jour fixé par la Loi comme point de départ”
Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
No statutory auditor

Articles of association, deed of 02-07-2024 (in French)

Network & group

MINICARE shares no director with another company.

Connections & network

1 current director
Depth

The network starts from the directors of MINICARE. Every other company they run is a node.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

Timeline

Acts, filings and financial milestones

2026
25-08
NBB filing Annual accounts 2025 filedNBB
micro format · 25 days late
2024
30-12
Gazette deed Registered office moved from Andenne to Waterloo
New seat: Avenue des merles, 12 à 1410 Waterloo · Previous seat: Rue de Belle-Vue 2 boîte A-SS, 5300 Andenne, Belgique2 points ▸
  • Registered-office move, Avenue des merles,12 à 1410 Waterloo
  • Board meeting, 01-08-2024

Open the act in the Belgian Official Gazette

02-07
Gazette deed Incorporation
Starting capital €2,000 · Appointment: MAGERMAN Clémentine Jean-Louis Elisabeth Michèle Murielle (director) · Founder10 points ▸
  • Incorporation, 27-06-2024
  • Founder, MAGERMAN Clémentine Jean-Louis Elisabeth Michèle Murielle
  • Founding capital, €2,000
  • Other provision, “loi, effectivité décisions transitoires” (deed in French)
  • Registered office clause, /, “5300 Andenne,Rue de Belle-Vue 2A-SS” (deed in French)
  • Board rule, 1
  • Director appointment, MAGERMAN Clémentine Jean-Louis Elisabeth Michèle Murielle (director (not named in the articles))
  • Declaration, “vérification interdictions de gérer, pas d'interdiction civile ou pénale” (deed in French)
  • Declaration, “absence interdiction de gérer” (deed in French)
  • Pre-incorporation commitments, “takeover, engagements,obligations,activités au nom et pour compte société en formation” (deed in French)

Open the act in the Belgian Official Gazette

Gazette deedNBB filing

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

On 28 June 2024, MINICARE was incorporated as a private limited company by one natural person, with a starting capital of €2,000.12 In 2024 the registered office moved to Waterloo.3 MAGERMAN Clémentine Jean-Louis Elisabeth Michèle Murielle has served as director since 2024.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 02-07-2024
  3. 3Belgian Official Gazette, 30-12-2024
  4. 4National Bank, annual accounts 2025

Company details

Register details

Identity

KBO record
Name MINICARE in French
Enterprise number 1010.914.501
Legal form Private limited company
Status Active, normale toestand
Founded 28-06-2024
Entity type Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 02-07-2024 (in French)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Région Wallonne, créés, en Belgique ou à l’étranger, par décision de l’organe d’administration”
deed of 02-07-2024 (in French)

Registered office and establishments

Registered office Avenue des Merles 12, 1410 Waterloo, Belgium
1 former office
  • Rue de Belle-Vue 2 boîte A-SS, 5300 Andenne until 01-08-2024 · act of 30-12-2024
Establishment unit Avenue des Merles 12, 1410 Waterloo since 01-08-2024 · unit number 2.366.784.16286220 Specialist medical practice

Activities

PurposeThe purpose describes the activities the company may carry out under its articles.
“L'exercice, en son nom et pour son compte, de la médecine, plus particulièrement de la médecine pédiatrique, et par l'intermédiaire de ses…”
19 activities
  1. L'exercice, en son nom et pour son compte, de la médecine, plus particulièrement de la médecine pédiatrique, et par l'intermédiaire de ses organes médecins, légalement habilités à pratiquer la médecine en Belgique, inscrit au Tableau de l'Ordre des Médecins selon les règles de la déontologie médicale
  2. D'organiser des services généraux et un secrétariat médical en particulier pour y exercer les activités
  3. La société a pour but de leur permettre de pratiquer une médecine de qualité, dans le respect de la déontologie et de la liberté thérapeutique et diagnostique et au libre choix du médecin par le patient, de la dignité et de l'indépendance professionnelle
  4. En assurant la gestion d'un centre médical ou d'un cabinet médical, en ce compris l'acquisition, la location et l'entretien du matériel médical et des biens d'équipement, la facturation et la perception d'honoraires médicaux, la mise à disposition de tout ce qui est nécessaire à la pratique de l'art de guérir
  5. En permettant la création, la construction, la location, l'acquisition, l'organisation et la fonctionnement d'un cabinet médical ou d'un centre médical de nature à faciliter l'exercice de la profession de médecin
  6. En assurant la défense des intérêts professionnels, moraux et matériels des médecins travaillant dans le cadre de la société
  7. La société se donne également pour objet de favoriser la recherche scientifique en organisant des activités de recyclage et en nouant avec tous les organismes poursuivant les mêmes buts, les relations nécessaires à la réalisation de son objet
  8. La société pourra faire tout acte nécessaire et/ou indispensable à l'accomplissement de son objet et plus particulièrement toute transaction mobilière et immobilière concernant les locaux médicaux, l'achat du matériel médical et non médical, l'engagement du personnel administratif, soignant pratiquant ou appelé a pratiquer dans la société
  9. Elle ne pourra cependant poser aucun acte quelconque que dans le strict respect des règles de la déontologie médicale
  10. La société pourra d'une façon générale accomplir toutes opérations se rapportant directement ou indirectement à la réalisation de son objet social, sans caractère répétitif et commercial et sans en modifier sa vocation médicale
  11. L'objet ne pourra être poursuivi que dans le respect des prescriptions d'ordre déontologique, notamment celles relatives au livre choix du médecin par le patient, à l'indépendance professionnelle du praticien
  12. La société s'interdit toute exploitation commerciale de la médecine, toute forme de collusion directe ou indirecte, de dichotomie ou de surconsommation
  13. La société pour louer ou sous-louer, acquérir des droits réels ou la pleine propriété de tout immeuble dans le but soit d'y établir son siège social, soit un siège d'activité ou d'y loger ses dirigeants et les membres en ligne directe de leur famille sans que cela motive la vacation médicale de la société
  14. Elle pourra s'intéresser par voie d'apport, de fusion, de souscription ou de toute autre manière, dans toutes entreprises, associations ou sociétés ayant un objet similaire, analogue ou connexe, ou de nature à favoriser celui de la société sous réserve d'en informer le Conseil Provincial intéressé de l'Ordre des Médecins et pour autant que cette participation fasse l'objet également d'un contrat
  15. A titre accessoire, la société peut également avoir pour objet la constitution, et la valorisation d'un patrimoine immobilier, notamment par l'achat, la vente, la location, la mes en location, la construction, le tout au sens le plus large, pour autant que n'en soient altérés sa vocation prioritairement médicale, et que ces opérations s'inscrivant dans les limites d'une gestion n'aient pas un caractère répétitif et commercial
  16. Dès lors qu'il y a plusieurs actionnaires, un accord préalable, par les actionnaires est à prévoir sur la politique de constitution et de gestion des investissements ainsi réalisés
  17. Les modalités d'investissement doivent être approuvées, au préalable, par les actionnaires, à une majorité des deux-tiers minimum
  18. En cas de pluralité d'actionnaires, ceux-ci mettent en commun la totalité de leur activité médicale au sein de la société
  19. Au cas où la prestation de certains actes serait soumise à des conditions préalables d'accès à la profession, la société subordonnera son action, en ce qui concerne la prestation de ces actes, à la réalisation de ces conditions
deed of 02-07-2024 (in French)

Invoicing and payment

VAT number BE 1010.914.501
E-invoicing via Peppol
Reachable via Peppol
Peppol ID 0208:1010914501
Other Peppol ID 9925:BE1010914501
Registered 01-07-2025

Follow this company and you will hear the next morning if it leaves the Peppol register.

Register as of 4 November 2026 · Peppol Directory

Financial year and general meeting

Accounts at the NBB
Financial year end 31-12
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Monday of June
deed of 02-07-2024 (in French)

Sites & property

Location
registered office establishment The establishment unit on the map

Buildings and parcels at the address

Ground area
667 m²
Building footprint
62 m²
Building volume
431 m³
Cadastral parcel Region Area Buildings Height / floors
25763I0828/00B000 Wallonia 666 m² 1 · 62 m² 10.4 m · 2